HLA-C and cancer: Moreover, the creation of algorithms to predict the binding of epitopes to MHC molecules has facilitated the identification of potentially immunogenic neoepitopes, which may provide fresh perspectives on cancer immunotherapy and is expected to improve the clinical prognosis of cancer patients (19, 20).